Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 9
Submit an article Journal homepage
3,332
Views
4
CrossRef citations to date
0
Altmetric
Articles

Open-label, phase 2 study of blinatumomab after frontline R-chemotherapy in adults with newly diagnosed, high-risk DLBCL

Deborah A. Katza Division of Hematology/Oncology/Cell Therapy, Rush University Medical Center, Chicago, IL, USACorrespondence[email protected]
,
Joan D. Morrisb Amgen Inc, Thousand Oaks, CA, USA
,
Michael P. Chuc Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Canada
,
Kevin A. Davidd Rutgers Cancer Institute of New Jersey, Rutgers Wood Johnson Medical School, New Brunswick, NJ, USA
,
Catherine Thieblemonte APHP, Hôpital Saint-Louis, Hemato-Oncology Unit Paris, France;f Diderot University, Paris, France
,
Nicholas J. Morleyg Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
,
Sharif S. Khanh Hematology & Oncology, Bon Secours St. Francis, Greenville, SC, USA
,
Andreas Viardoti Department of Internal Medicine III, University Hospital Ulm, Ulm, GermanyORCID Iconhttps://orcid.org/0000-0001-9593-6327
ORCID Icon,
Alejandro Martín García-Sanchoj Hospital Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain
,
Guillermo Rodríguez-Garcíak Servicio de Hematología, Hospital Virgen del Rocío, Seville, Spain
,
Mariana Bastos-Oreirol Haematology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain
,
Seung Tae Leem Division of Hematology/Oncology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA
,
William Kormanyb Amgen Inc, Thousand Oaks, CA, USA
,
Yuqi Chenb Amgen Inc, Thousand Oaks, CA, USA
,
Hansen L. Wongn Amgen Inc, South San Francisco, CA, USA
,
Abraham A. Andersonb Amgen Inc, Thousand Oaks, CA, USA
,
Yuliya Katlinskayan Amgen Inc, South San Francisco, CA, USA
,
Ariel A. Avilionn Amgen Inc, South San Francisco, CA, USA
,
Tian Daib Amgen Inc, Thousand Oaks, CA, USA
&
Eva González-Barcao Hematology, IDIBELL, Institut Català d'Oncologia, Universitat de Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain
 show all
Pages 2063-2073 | Received 29 Sep 2021, Accepted 03 Apr 2022, Published online: 03 May 2022

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Dustin McCurry, Christopher R. Flowers & Casey Bermack. (2023) Immune-based therapies in diffuse large B-cell lymphoma. Expert Opinion on Investigational Drugs 32:6, pages 479-493.
Read now
Meixiao Long, Alice S. Mims & Zihai Li. (2022) Factors Affecting the Cancer Immunotherapeutic Efficacy of T Cell Bispecific Antibodies and Strategies for Improvement. Immunological Investigations 51:8, pages 2176-2214.
Read now

Articles from other publishers (2)

Afua Adjeiwaa Mensah & Patrizia Mondello. (2022) Harnessing the Molecular Fingerprints of B Cell Lymphoma for Precision Therapy. Journal of Clinical Medicine 11:19, pages 5834.
Crossref
Ha Gyeong Shin, Ha Rim Yang, Aerin Yoon & Sukmook Lee. (2022) Bispecific Antibody-Based Immune-Cell Engagers and Their Emerging Therapeutic Targets in Cancer Immunotherapy. International Journal of Molecular Sciences 23:10, pages 5686.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.